This site is intended only for the use of UK Healthcare Professionals

Nestlé N&H

From April 2026, our nutrition and health businesses have come together to form a single Nutrition & Health organisation.

For you and your patients, this means bringing together our expertise across everyday nutrition and specialised medical nutrition, so we can better support care across all life stages.

Importantly, this change also enables us to:

  • Strengthen our evidence base, with greater investment in clinical research and real-world insights
  • Accelerate innovation, helping bring new and improved solutions to patients faster
  • Enhance how we deliver for you, with a more joined-up and consistent approach across our portfolio

Over the coming months, you will begin to see our new Nutrition & Health branding. Please be reassured that this is simply a change in name and appearance, our products, the way we work, and your local contact remain the same. You can continue to expect the same support and partnership as always.

CINNAMON Study Video

HMO Hub
HMO Hub
  • 16/07/2026
CINNAMON Study Video

Video description

Breastmilk remains the nutritional gold standard for all infants, including those with Cow's Milk Protein Allergy (CMPA). Building on decades of pioneering research, Nestlé Health Science continues to innovate by bringing structurally identical Human Milk Oligosaccharides (HMOs) to hypoallergenic formula.
This video explores findings from the CINNAMON Study, a randomized, controlled, double-blind clinical trial evaluating a hypoallergenic formula enhanced with two HMOs. The study demonstrated effective relief of CMPA symptoms, fewer respiratory infections, and a gut microbiota profile closer to that of breastfed infants.

Other content you might be interested in
IVORY Study Video
HMO Hub
HMO Hub

VIDEOS

IVORY Study Video

Human Milk Oligosaccharides (HMOs) are third largest solid component of breastmilk that help support the development of an infant's immune system. After decades of research, Nestlé Health Science has become the first to incorporate two structurally identical HMOs, 2'FL and LNnT, into a hypoallergenic formula.This video highlights findings from the IVORY Study, the first study of its kind to assess HMOs in infants and young children with Cow's Milk Protein Allergy (CMPA). Discover how the formula demonstrated safety, tolerance, and compliance with gold-standard clinical hypo allergenicity requirements, offering clinicians a new option for nutritional management of CMPA.
An introduction to HMOs and their benefits in infants with cow’s milk protein allergy
HMO Hub
HMO Hub

VIDEOS

An introduction to HMOs and their benefits in infants with cow’s milk protein allergy

Discover more about the importance of Human Milk Oligosaccharides (HMOs) in infant nutrition, particularly for infants with cow’s milk protein allergy (CMPA). Watch this webinar, delivered by Dr Sophie Nutten, to enhance your knowledge.
What are HMOs?
HMO Hub
HMO Hub

VIDEOS

What are HMOs?

This video offers an introduction to human milk oligosaccharides (HMOs), a key component of human milk. In this introduction we look at what HMOs are, how they are formed and how their benefits are linked to their unique structures.
The Role of HMOs
HMO Hub
HMO Hub

VIDEOS

The Role of HMOs

This video provides a brief overview of how human milk oligosaccharides (HMOs) support immune protection — showing how they block pathogen adhesion, promote beneficial microbiota, and help modulate epithelial and immune cell responses to strengthen earlylife immunity.
The HMO Journey
HMO Hub
HMO Hub

VIDEOS

The HMO Journey

This video looks at the HMO journey—decades of scientific research that have deepened our understanding of what human milk oligosaccharides (HMOs) are and how they contribute to the development of infant immunity. It highlights how this evidence base has enabled Nestlé to incorporate key HMOs into specialist infant formulas, supporting continued innovation.
2’FL and LNnT for the management of CMPA
HMO Hub
HMO Hub

VIDEOS

2’FL and LNnT for the management of CMPA

This video focuses on two of the most abundant and wellresearched human milk oligosaccharides (HMOs) - 2′FL and LNnT. It outlines their roles in supporting immune function, strengthening the gut barrier, and modulating microbiota, and how these mechanisms support with the dietary management of cow’s milk protein allergy (CMPA).